Artículos por temáticas

Does Functional Connectivity Provide a Marker for Cognitive Rehabilitation Effects in Alzheimer's Disease? An Interventional Study

Ochmann S, Dyrba M, Grothe MJ, Kasper E, Webel S, Hauenstein K, Teipel SJ.

J Alzheimers Dis. 2017;57(4):1303-1313. doi: 10.3233/JAD-160773.

Efficacy and safety of a novel acetylcholinesterase inhibitor octohydroaminoacridine in mild-to-moderate Alzheimer's disease: a Phase II multicenter randomised controlled trial

Xiao S, Wang T, Ma X, Qin Y, Li X, Zhao Z, Liu X, Wang X, Xie H, Jiang Q, Sun L, Luo B, Shang L, Chen W, Bai Y, Tang M, He M, Wu L, Ma Q, Hou D, He J.

Age Ageing. 2017 Sep 1;46(5):767-773. doi: 10.1093/ageing/afx045.

Changes in brain amyloid-β accumulation after donepezil administration

Ishibashi K, Miura Y, Wagatsuma K, Ishiwata K, Ishii K.

J Clin Neurosci. 2017 Nov;45:328-329. doi: 10.1016/j.jocn.2017.08.025. Epub 2017 Aug 31.

Bryostatin Effects on Cognitive Function and PKCɛ in Alzheimer's Disease Phase IIa and Expanded Access Trials

Nelson TJ, Sun MK, Lim C, Sen A, Khan T, Chirila FV, Alkon DL.

J Alzheimers Dis. 2017;58(2):521-535. doi: 10.3233/JAD-170161.

Saitohin Q7R polymorphism is associated with late-onset Alzheimer's disease susceptibility among caucasian populations: a meta-analysis

Huang R, Tian S, Cai R, Sun J, Xia W, Dong X, Shen Y, Wang S.

J Cell Mol Med. 2017 Aug;21(8):1448-1456. doi: 10.1111/jcmm.13079. Epub 2017 Feb 17.

Clinical, imaging, pathological, and biochemical characterization of a novel presenilin 1 mutation (N135Y) causing Alzheimer's disease

Natelson Love M, Clark DG, Cochran JN, Den Beste KA, Geldmacher DS, Benzinger TL, Gordon BA, Morris JC, Bateman RJ, Roberson ED.

Neurobiol Aging. 2017 Jan;49:216.e7-216.e13. doi: 10.1016/j.neurobiolaging.2016.09.020. Epub 2016 Oct 3.

Functional and effective brain connectivity for discrimination between Alzheimer's patients and healthy individuals: A study on resting state EEG rhythms

Blinowska KJ, Rakowski F, Kaminski M, De Vico Fallani F, Del Percio C, Lizio R, Babiloni C.

Clin Neurophysiol. 2017 Apr;128(4):667-680. doi: 10.1016/j.clinph.2016.10.002. Epub 2016 Oct 22.

Creutzfeldt-Jakob Disease Mimicking Alzheimer Disease and Dementia With Lewy Bodies-Findings of FDG PET With 3-Dimensional Stereotactic Surface Projection

Miyazawa N.

Clin Nucl Med. 2017 May;42(5):e247-e248. doi: 10.1097/RLU.0000000000001602.

Baseline Telomere Length and Effects of a Multidomain Lifestyle Intervention on Cognition: The FINGER Randomized Controlled Trial

Sindi S, Ngandu T, Hovatta I, Kåreholt I, Antikainen R, Hänninen T, Levälahti E, Laatikainen T, Lindström J, Paajanen T, Peltonen M, Khalsa DS, Wolozin B, Strandberg T, Tuomilehto J, Soininen H, Kivip

J Alzheimers Dis. 2017;59(4):1459-1470. doi: 10.3233/JAD-170123.

Evaluation and clinical correlation of practical cut-offs for visual rating scales of atrophy: normal aging versus mild cognitive impairment and Alzheimer's disease

Vanhoenacker AS, Sneyers B, De Keyzer F, Heye S, Demaerel P.

Acta Neurol Belg. 2017 Sep;117(3):661-669. doi: 10.1007/s13760-017-0777-8. Epub 2017 Apr 10.

Poor Safety and Tolerability Hamper Reaching a Potentially Therapeutic Dose in the Use of Thalidomide for Alzheimer's Disease: Results from a Double-Blind, Placebo-Controlled Trial

Decourt B, Drumm-Gurnee D, Wilson J, Jacobson S, Belden C, Sirrel S, Ahmadi M, Shill H, Powell J, Walker A, Gonzales A, Macias M, Sabbagh MN.

Curr Alzheimer Res. 2017;14(4):403-411. doi: 10.2174/1567205014666170117141330.

Searching for new pharmacological targets for the treatment of Alzheimer's disease in Down syndrome

Caraci F, Iulita MF, Pentz R, Flores Aguilar L, Orciani C, Barone C, Romano C, Drago F, Cuello AC.

Eur J Pharmacol. 2017 Dec 15;817:7-19. doi: 10.1016/j.ejphar.2017.10.004. Epub 2017 Oct 5.

Study protocol: pragmatic randomized control trial of an internet-based intervention (My tools 4 care) for family carers

Duggleby W, Ploeg J, McAiney C, Fisher K, Swindle J, Chambers T, Ghosh S, Peacock S, Markle-Reid M, Triscott J, Williams A, Forbes D, Pollard L.

BMC Geriatr. 2017 Aug 14;17(1):181. doi: 10.1186/s12877-017-0581-6.

7T MRI for neurodegenerative dementias in vivo: a systematic review of the literature

McKiernan EF, O'Brien JT.

J Neurol Neurosurg Psychiatry. 2017 Jul;88(7):564-574. doi: 10.1136/jnnp-2016-315022. Epub 2017 Mar 4.

Potential oxidative stress biomarkers of mild cognitive impairment due to Alzheimer disease

García-Blanco A, Baquero M, Vento M, Gil E, Bataller L, Cháfer-Pericás C.

J Neurol Sci. 2017 Feb 15;373:295-302. doi: 10.1016/j.jns.2017.01.020. Epub 2017 Jan 7.